7.67 USD
+0.26 (+3.51%)
Taking everything into account, BVS scores 5 out of 10 in our fundamental rating. BVS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. A decent growth rate in combination with a cheap valuation! Better keep an eye on BVS.
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
In the past year BVS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BVS's Return On Assets of 1.11% is fine compared to the rest of the industry. BVS outperforms 75.00% of its industry peers.
Looking at the Return On Equity, with a value of 4.71%, BVS is in the better half of the industry, outperforming 76.06% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.62%, BVS belongs to the top of the industry, outperforming 80.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROIC | 6.62% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a better Profit Margin (1.39%) than 73.94% of its industry peers.
BVS's Operating Margin of 8.03% is fine compared to the rest of the industry. BVS outperforms 75.00% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 67.76%, BVS is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
Compared to 1 year ago, BVS has more shares outstanding
Compared to 5 years ago, BVS has more shares outstanding
Compared to 1 year ago, BVS has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.21, we must say that BVS is in the distress zone and has some risk of bankruptcy.
BVS's Altman-Z score of 1.21 is in line compared to the rest of the industry. BVS outperforms 52.66% of its industry peers.
The Debt to FCF ratio of BVS is 6.22, which is on the high side as it means it would take BVS, 6.22 years of fcf income to pay off all of its debts.
BVS's Debt to FCF ratio of 6.22 is fine compared to the rest of the industry. BVS outperforms 76.06% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that BVS has dependencies on debt financing.
BVS's Debt to Equity ratio of 1.93 is on the low side compared to the rest of the industry. BVS is outperformed by 81.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Altman-Z | 1.21 |
ROIC/WACC0.78
WACC8.47%
2.3 Liquidity
BVS has a Current Ratio of 1.74. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.74, BVS is doing worse than 69.68% of the companies in the same industry.
A Quick Ratio of 1.14 indicates that BVS should not have too much problems paying its short term obligations.
BVS has a worse Quick ratio (1.14) than 72.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 51.28% over the past year.
BVS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.93% yearly.
Looking at the last year, BVS shows a small growth in Revenue. The Revenue has grown by 1.58% in the last year.
BVS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.01% yearly.
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
3.2 Future
The Earnings Per Share is expected to grow by 28.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.48% on average per year.
EPS Next Y37.53%
EPS Next 2Y33.95%
EPS Next 3Y28.18%
EPS Next 5YN/A
Revenue Next Year0.32%
Revenue Next 2Y3.71%
Revenue Next 3Y4.48%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.00, BVS is valued correctly.
Based on the Price/Earnings ratio, BVS is valued cheaper than 89.89% of the companies in the same industry.
BVS is valuated rather cheaply when we compare the Price/Earnings ratio to 25.65, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.09, the valuation of BVS can be described as very reasonable.
Based on the Price/Forward Earnings ratio, BVS is valued cheaper than 95.21% of the companies in the same industry.
BVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13 | ||
| Fwd PE | 9.09 |
4.2 Price Multiples
BVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BVS is cheaper than 92.55% of the companies in the same industry.
96.28% of the companies in the same industry are more expensive than BVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.86 | ||
| EV/EBITDA | 9.71 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BVS's earnings are expected to grow with 28.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y33.95%
EPS Next 3Y28.18%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BVS (11/25/2025, 12:28:17 PM)
7.67
+0.26 (+3.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners73.56%
Inst Owner Change1.06%
Ins Owners2.54%
Ins Owner Change2.9%
Market Cap634.16M
Revenue(TTM)563.83M
Net Income(TTM)7.82M
Analysts80
Price Target15.3 (99.48%)
Short Float %3.26%
Short Ratio6.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.08%
Min EPS beat(2)-0.99%
Max EPS beat(2)29.14%
EPS beat(4)3
Avg EPS beat(4)86.47%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)133.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)0.07%
Revenue beat(4)2
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)4.79%
Revenue beat(8)6
Avg Revenue beat(8)4.08%
Revenue beat(12)9
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)1.33%
PT rev (1m)2.27%
PT rev (3m)7.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.27%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.52%
Revenue NQ rev (1m)-0.32%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13 | ||
| Fwd PE | 9.09 | ||
| P/S | 1.12 | ||
| P/FCF | 11.86 | ||
| P/OCF | 11.32 | ||
| P/B | 3.82 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.71 |
EPS(TTM)0.59
EY7.69%
EPS(NY)0.84
Fwd EY11%
FCF(TTM)0.65
FCFY8.43%
OCF(TTM)0.68
OCFY8.83%
SpS6.82
BVpS2.01
TBVpS-2.65
PEG (NY)0.35
PEG (5Y)N/A
Graham Number5.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.11% | ||
| ROE | 4.71% | ||
| ROCE | 8.38% | ||
| ROIC | 6.62% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 31.69% | ||
| OM | 8.03% | ||
| PM (TTM) | 1.39% | ||
| GM | 67.76% | ||
| FCFM | 9.48% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y44.62%
ROICexgc growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score8
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | 6.22 | ||
| Debt/EBITDA | 3.44 | ||
| Cap/Depr | 5.36% | ||
| Cap/Sales | 0.45% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 60.26% | ||
| Profit Quality | 683.69% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 1.21 |
F-Score8
WACC8.47%
ROIC/WACC0.78
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.28%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y37.53%
EPS Next 2Y33.95%
EPS Next 3Y28.18%
EPS Next 5YN/A
Revenue 1Y (TTM)1.58%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-0.23%
Revenue Next Year0.32%
Revenue Next 2Y3.71%
Revenue Next 3Y4.48%
Revenue Next 5YN/A
EBIT growth 1Y178.93%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.75%
EBIT Next 3Y12.98%
EBIT Next 5YN/A
FCF growth 1Y29806.1%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y448.75%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%
BIOVENTUS INC - A / BVS FAQ
Can you provide the ChartMill fundamental rating for BIOVENTUS INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to BVS.
What is the valuation status of BIOVENTUS INC - A (BVS) stock?
ChartMill assigns a valuation rating of 8 / 10 to BIOVENTUS INC - A (BVS). This can be considered as Undervalued.
Can you provide the profitability details for BIOVENTUS INC - A?
BIOVENTUS INC - A (BVS) has a profitability rating of 5 / 10.
How financially healthy is BIOVENTUS INC - A?
The financial health rating of BIOVENTUS INC - A (BVS) is 3 / 10.
What is the earnings growth outlook for BIOVENTUS INC - A?
The Earnings per Share (EPS) of BIOVENTUS INC - A (BVS) is expected to grow by 37.53% in the next year.